WHITE PAPER | CHINA
BioCentury Real-World Evidence Spotlight Collection
November 23, 2021 12:00 AM UTC
BioCentury's spotlight on "Real-World Evidence" highlights BioCentury's recent coverage and analysis into the opportunities for Western pharmaceutical companies to accelerate drug development processes in China using the Real World Evidence (RWE) approval pathway.
Summary text goes here.